Accriva Diagnostics

San Diego, United States Founded: 2009 • Age: 17 yrs Acquired By Instrumentation Laboratory
Near-patient diagnostic systems for coagulation testing are developed.
Request Access

About Accriva Diagnostics

Accriva Diagnostics is a company based in San Diego (United States) founded in 2009 was acquired by Instrumentation Laboratory in January 2017.. Accriva Diagnostics has raised $216.01 million across 6 funding rounds from investors including Kleiner Perkins, Werfen and Warburg Pincus. The company has 399 employees as of December 31, 2017. Accriva Diagnostics has completed 1 acquisition, including Accumetrics. Accriva Diagnostics operates in a competitive market with competitors including Diagnostica Stago, Entegrion, Enzyre, MedicQuant ApS and Perosphere, among others.

  • Headquarter San Diego, United States
  • Employees 399 as on 31 Dec, 2017
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $216.01 M (USD)

    in 6 rounds

  • Latest Funding Round
    $15.47 M (USD), Private Equity Round

    Mar 10, 2015

  • Investors
  • Employee Count
    399

    as on Dec 31, 2017

  • Investments & Acquisitions
  • Acquired by
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Accriva Diagnostics

Accriva Diagnostics has successfully raised a total of $216.01M across 6 strategic funding rounds. The most recent funding activity was a Private Equity Round round of $15.47 million completed in March 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 6
  • Last Round Private Equity Round — $15.5M
  • First Round
  • Investors Count 4
Date Amount Transaction Name Valuation Lead Investors Investors
Mar, 2015 Amount Private Equity Round - Accriva Diagnostics Valuation Bay City Capital , Warburg Pincus
Mar, 2014 Amount Private Equity Round - Accriva Diagnostics Valuation

investors

Mar, 2014 Amount Debt – Venture - Accriva Diagnostics Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Accriva Diagnostics

Accriva Diagnostics has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Kleiner Perkins, Werfen and Warburg Pincus. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Stage-agnostic investments in US life-sciences sectors are managed.
Founded Year Domain Location
Multi-stage private equity investments are pursued across diverse sectors.
Founded Year Domain Location
Venture capital firm investing in early-stage tech startups
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Accriva Diagnostics

Accriva Diagnostics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Accumetrics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Platelet function assays and coagulation systems are developed and marketed.
1996
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Accriva Diagnostics

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Accriva Diagnostics Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Accriva Diagnostics

Accriva Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Diagnostica Stago, Entegrion, Enzyre, MedicQuant ApS and Perosphere, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
A portfolio of hemostasis and coagulation diagnostic products is manufactured.
domain founded_year HQ Location
Hemostasis and fluid replacement products are provided for medical applications.
domain founded_year HQ Location
Smart diagnostics devices for blood coagulation analysis are developed.
domain founded_year HQ Location
Diagnostic kits for blood anticoagulant detection are provided.
domain founded_year HQ Location
Anticoagulant reversal agent and small molecules to prevent allergic reactions, traumatic brain injury.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Accriva Diagnostics

Frequently Asked Questions about Accriva Diagnostics

When was Accriva Diagnostics founded?

Accriva Diagnostics was founded in 2009.

Where is Accriva Diagnostics located?

Accriva Diagnostics is headquartered in San Diego, United States. It is registered at San Diego, California, United States.

Is Accriva Diagnostics a funded company?

Accriva Diagnostics is a funded company, having raised a total of $216.01M across 6 funding rounds to date. The company's 1st funding round was a Debt – Venture of $21M, raised on Mar 01, 2009.

How many employees does Accriva Diagnostics have?

As of Dec 31, 2017, the latest employee count at Accriva Diagnostics is 399.

What does Accriva Diagnostics do?

Accriva Diagnostics was founded in 2009 and is headquartered in San Diego, United States. Operations focus on the medical diagnostics sector, where near-patient testing systems are developed and commercialized. Products include a compact microcoagulation monitoring system with tests such as ACT, PT, and APTT; whole blood coagulation analyzers; heel and finger incision devices for newborns and general use; the Avoximeter 1000E oximeter; and antiplatelet reactivity testing devices.

Who are the top competitors of Accriva Diagnostics?

Accriva Diagnostics's top competitors include Diagnostica Stago, MedicQuant ApS and Enzyre.

How many acquisitions has Accriva Diagnostics made?

Accriva Diagnostics has made 1 acquisition, including Accumetrics.

Who are Accriva Diagnostics's investors?

Accriva Diagnostics has 6 investors. Key investors include Kleiner Perkins, Werfen, Warburg Pincus, Instrumentation Laboratory, and Blackrockbkcc.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available